Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07313176) titled 'Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease' on Dec. 17, 2025.
Study Type: Observational
Primary Sponsor: Britannia Pharmaceuticals Ltd.
Condition:
Advanced Parkinson Disease
Intervention:
Other: No Intervention
Recruitment Status: Not recruiting
Date of First Enrollment: January 2026
Target Sample Size: 215
To know more, visit https://clinicaltrials.gov/study/NCT07313176
Published by HT Digital Content Services with permission from Health Daily Digest....